Related Experiment Video
Updated: Mar 22, 2026

Treatment of Osteochondral Defects in the Rabbit's Knee Joint by Implantation of Allogeneic Mesenchymal Stem Cells in Fibrin Clots
Published on: May 21, 2013
Stem cells in articular cartilage regeneration.
Giuseppe Filardo1, Francesco Perdisa1, Alice Roffi2
1II Orthopaedic and Traumatologic Clinic, Rizzoli Orthopaedic Institute, Bologna, Italy.
Mesenchymal stem cells (MSCs) show promise for cartilage repair and early osteoarthritis, with most studies reporting clinical benefits and no major adverse events. Further high-quality research is needed to confirm efficacy and optimize treatment strategies.
Area of Science:
- Orthopedics and Regenerative Medicine
- Cell Therapy and Tissue Engineering
- Biomedical Research
Background:
- Mesenchymal stem cells (MSCs) are explored for treating articular defects and early osteoarthritis (OA).
- Clinical application of MSCs faces controversy regarding their efficacy and limitations.
- A systematic review is needed to consolidate evidence on MSC treatment strategies for cartilage lesions and OA.
Purpose of the Study:
- To systematically review clinical studies on Mesenchymal stem cells (MSCs) treatment strategies.
- To summarize current evidence on the efficacy of MSCs for cartilage lesions and osteoarthritis (OA).
- To identify factors influencing MSC therapy outcomes and optimal delivery methods.
Main Methods:
- Systematic review of 60 selected studies (7 randomized, 13 comparative, 31 case series, 9 case reports).
- Analysis of studies based on administration method (injective vs. surgical implantation) and cell source (BMSCs, ADSCs, BMC, PBSCs, SDSCs).
- Evaluation of reported clinical outcomes, adverse events, and influencing factors.
Main Results:
- No major adverse events were reported for MSC treatment or cell harvest.
- Most studies reported clinical benefits of MSC therapies, supported by clinical, MRI, and macroscopic findings, though histologic results were mixed.
- Younger age, lower BMI, smaller lesion size, and earlier OA stages correlated with better outcomes.
- Cultured MSCs were often administered via intra-articular injection, while cell concentrates favored surgical implantation.
Conclusions:
- While MSC therapies show promise for cartilage repair and OA, robust clinical data from high-level studies are required for confirmation.
- Further research should focus on optimizing cell sources, manipulation, delivery techniques, and identifying ideal indications based on pathology and disease phase.
- Standardized, well-designed prospective studies are essential to establish definitive evidence for MSC efficacy in orthopedic applications.
Related Concept Videos
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Mesenchymal Stem Cells
Growth of Cartilage and Bone Tissue
Stem Cell Culture
Tissue Renewal without Stem Cells
However, failure of such a system...
Adult Stem Cells

